Targeting Dual Immune Checkpoints PD‐L1 and HLA‐G by Trispecific T Cell Engager for Treating Heterogeneous Lung Cancer
Abstract
Research context
OpenAlex topics: Immunotherapy and Immune Responses · CAR-T cell therapy research · Cancer Immunotherapy and Biomarkers
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Translational Cell Therapy Center China Medical University Hospital No. 2, Yude Rd., North Dist. Taichung City 404 Taiwan
Shine‐On BioMedical Co. Ltd. Rm. B, 10F., No. 573, Sec. 2, Taiwan Blvd., West Dist. Taichung City 403 Taiwan
Institute of New Drug Development China Medical University Taichung City 404 Taiwan
Institute of Biomedical Sciences National Chung Hsing University Taichung City 402 Taiwan
Department of Food Science and Biotechnology National Chung Hsing University Taichung City 402 Taiwan
Center for Translational Genomics and Regenerative Medicine Research China Medical University Hospital Taichung City 404 Taiwan
Department of Ophthalmology China Medical University Hospital China Medical University Taichung City 404 Taiwan
Department of Medical Research Eye Center China Medical University Hospital Taichung City 404 Taiwan
College of Medicine China Medical University Taichung City 404 Taiwan
Division of Nephrology and the Kidney Institute Department of Internal Medicine China Medical University Hospital Taichung City 404 Taiwan
Division of Pulmonary and Critical Care Department of Internal Medicine China Medical University Hospital Taichung City 404 Taiwan
School of Medicine College of Medicine China Medical University Taichung City 404 Taiwan
Drug Development Center China Medical University Taichung City 404 Taiwan
Department of Neurosurgery China Medical University Hospital Taichung City 404 Taiwan
Funding
China Medical University Hospital